Artificial intelligence (AI) has the potential to significantly reduce pharmaceutical R&D costs by streamlining drug discovery, optimizing clinical trials, and minimizing costly failures through data-driven predictions and effectiveness assessments. This potential was acknowledged by the pharmaceutical industry professionals in a survey* conducted by GlobalData, a leading data and analytics company.
The post AI Set to Improve Pharmaceutical R&D Productivity and Lower the Costs Says GlobalData appeared first on HPCwire.
Article From: "Doug Eadline" Read full article »
Hire with PACE
The PACE robotics team specializes in placement for robotics, autonomous systems and industrial automation. Contact us today and let PACE find the talent to take your organization to the next level.
Talented Engineers Wanted
PACE aligns elite companies with the best and brightest, and we are always finding new opportunities for technical talent in Boston, Massachusetts, and New England. Submit your resume and let PACE start working for you.
